Characterization of CCK(A) receptor affinity states and Ca(2+) signal transduction in vagal nodose ganglia

Am J Physiol Gastrointest Liver Physiol. 2002 Jun;282(6):G1002-8. doi: 10.1152/ajpgi.00313.2001.

Abstract

CCK(A) receptors are present on vagal afferent fibers. The objectives of this study were to identify the presence of high- and low-affinity CCK(A) receptors on nodose ganglia and to characterize the intracellular calcium signal transduction activated by CCK. Stimulation of acutely isolated nodose ganglion cells from rats with 1 nM CCK-8 primarily evoked a Ca(2+) transient followed by a sustained Ca(2+) plateau (45% of cells responded), whereas 10 pM CCK-8 evoked Ca(2+) oscillations (37% of cells responded). CCK-OPE, a high-affinity agonist and low-affinity antagonist of CCK(A) receptors, primarily elicited Ca(2+) oscillations (29% of cells responded). CCK-OPE inhibited the Ca(2+) transient induced by 1 nM CCK-8 but not by carbachol and high K(+). This result suggests the presence of high- and low-affinity states of CCK(A) receptors on nodose ganglia. We further demonstrated that nicardipine (10 microM) but not omega-conotoxins GVIA and MVIIC (10-100 nM) abolished Ca(2+) signaling induced by CCK-8, indicating that an L-type voltage-dependent Ca(2+) channel and not an N- or Q-type Ca(2+) channel is coupled to CCK(A) receptors. In a separate study, we showed that the G protein activator NaF (10 mM) elicited a Ca(2+) transient and inhibited CCK-8-evoked Ca(2+) signaling, indicative of G protein(s) involvement in CCK(A) receptor activity. The G(q) protein antagonist Gp antagonist-2A (10 microM) also abolished the action of CCK-8. This study indicates that CCK(A) receptors exist in both high- and low-affinity states in the nodose ganglia. Activation of high-affinity CCK(A) receptors elicits Ca(2+) oscillations, whereas stimulation of low-affinity CCK(A) receptors evokes a sustained Ca(2+) plateau. These Ca(2+)-signaling modes are mediated through the L-type Ca(2+) channel and involve the participation of G(q) protein.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Affinity Labels / pharmacology
  • Animals
  • Calcium / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Dose-Response Relationship, Drug
  • GTP-Binding Proteins / metabolism
  • Male
  • Nodose Ganglion / metabolism*
  • Peptide Fragments / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cholecystokinin A
  • Receptors, Cholecystokinin / metabolism*
  • Sincalide / analogs & derivatives*
  • Sincalide / pharmacology

Substances

  • Affinity Labels
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Peptide Fragments
  • Receptor, Cholecystokinin A
  • Receptors, Cholecystokinin
  • cholecystokinin (26-32), Tyr-Gly-Nle(28,31) phenethyl ester-
  • GTP-Binding Proteins
  • Sincalide
  • Calcium